Results 211 to 220 of about 55,599 (265)

Corruption in the Pharmaceutical Sector

2017
Jillian Kohler
exaly   +2 more sources

The Indian Pharmaceutical Sector [PDF]

, 2002
This report assesses the pharmaceutical sector in India, particularly focusing on four key issues related to the production, procurement, and distribution of drugs in India: a) availability, b) affordability; c) quality, and d) the rational use of drugs.
Ramesh Govindaraj, Gnanaraj Chellaraj
openaire   +1 more source

Access to Healthcare and the Pharmaceutical Sector

Cambridge Quarterly of Healthcare Ethics, 2011
Health is higher on the international agenda than ever before, and improving the health of poor people is a central issue in development. Poor people suffer from far higher levels of ill health, mortality, and malnutrition than do those better off, and their inadequate health is one of the factors keeping them poor or for their being poor in the first ...
Klaus M, Leisinger, Karin M, Schmitt
openaire   +2 more sources

Pricing Policies in the Pharmaceutical Sector

Drug Information Journal, 2002
In this article we analyze the problem of determining the price for new drugs in a market where stringent budget constraints on public expenditure exists and we suggest an innovative methodology to set drug prices. The market is characterized by asymmetry of information and a high proportion of investment in research and development, an element that ...
Capri S., Levaggi R.
openaire   +2 more sources

Scope economies in the pharmaceutical sector

Rivista Internazionale di Scienze Economiche e Commerciali, 2006
The paper’s objectives are twofold: to propose an experimental simulation to measure scope economies between pairs of submarkets and to point out the role of submarkets in explaining the concentration level in the pharmaceutical market. We simulate scope economies consistent with the diversification choices of large international companies in the years
openaire   +2 more sources

Pharmaceutical sector: Delicate transition

Nature, 2012
With lay-offs rife in the drug industry, life scientists and chemists are seeking fresh career paths.
openaire   +2 more sources

The pharmaceuticals sector in Vietnam

2016
The fundamental goal of competition law is to support productivity and innovativeness; in fact, the short-term effect of enforcement actions is often a reduction in product prices. This book reports the findings of consumer market studies into a range of goods and services in developing countries in Africa, Asia and Latin America.
Que Anh Pham, Tran Phuong Lan
openaire   +1 more source

Blockchain in Pharmaceutical Sector

2020
The pharmaceutical research and development is a composite process that grabs lots of years in drug discovery, drug development and regulatory approval in the supply chain in the pharmaceutical sector. But due to the drugs counterfeiting, such as hidden, uncontrolled and outdated information of drug regulatory authority and manufacturers over drugs ...
Meet Kumari, Meenu Gupta, Chetanya Ved
openaire   +1 more source

Monopoly in the pharmaceutical sector

Pharmaceuticals Policy and Law, 2010
Almost every EU country has a form of regulation for the pharmaceutical sector, the level of which varies by country, motivated by the unique nature of medicine as a consumers good, different from any other good. In the majority of EU countries this circumstance allows the monopoly of the profession to extend to the dispensing of all medicine subject ...
openaire   +1 more source

Innovation, competition, and the pharmaceutical sector: theory and practice

Journal of European Competition Law & Practice
With high-technology markets coming increasingly under scrutiny from a competition law perspective, scholars and institutions have increasingly highlighted the relevance of innovation-related considerations in competition law analyses.Fortunately, there is a rich theoretical debate on the innovation-competition relationship, in particular by Smith ...
Jacquelyn Veraldi, Alicja Sołtykowska
openaire   +1 more source